Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119101197 | 11910119 | 7 | F | 2015 | 20160615 | 20160112 | 20160711 | PER | PR-PFIZER INC-2015349732 | PFIZER | 64.00 | YR | M | Y | 0.00000 | 20160711 | CN | PR | PR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119101197 | 11910119 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC (DAILY X 4 WEEKS, THEN 2 WEEKS OFF) | 21938 | 50 | MG | CAPSULE, HARD | |||||||
| 119101197 | 11910119 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | 50 MG, CYCLIC (28 DAYS ON/14 DAYS OFF) | 21938 | 50 | MG | CAPSULE, HARD | ||||||||
| 119101197 | 11910119 | 3 | C | AVAPRO | IRBESARTAN | 1 | 150 MG, UNK | 0 | 150 | MG | |||||||||
| 119101197 | 11910119 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MG, UNK | 0 | 20 | MG | |||||||||
| 119101197 | 11910119 | 5 | C | PREPARATION H NOS | COCOA BUTTERPETROLATUMPHENYLEPHRINE HYDROCHLORIDEPHENYLEPHRINE HYDROCHLORIDE OR MINERAL OIL | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119101197 | 11910119 | 1 | Renal cancer stage IV |
| 119101197 | 11910119 | 2 | Renal cancer |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119101197 | 11910119 | Abdominal discomfort | |
| 119101197 | 11910119 | Anorectal discomfort | |
| 119101197 | 11910119 | Asthenia | |
| 119101197 | 11910119 | Back pain | |
| 119101197 | 11910119 | Decreased appetite | |
| 119101197 | 11910119 | Diarrhoea | |
| 119101197 | 11910119 | Dry skin | |
| 119101197 | 11910119 | Dysgeusia | |
| 119101197 | 11910119 | Gingival discomfort | |
| 119101197 | 11910119 | Oral discomfort | |
| 119101197 | 11910119 | Oral pain | |
| 119101197 | 11910119 | Pain in extremity | |
| 119101197 | 11910119 | Palmar-plantar erythrodysaesthesia syndrome | |
| 119101197 | 11910119 | Skin disorder | |
| 119101197 | 11910119 | Skin hypertrophy | |
| 119101197 | 11910119 | Temperature intolerance | |
| 119101197 | 11910119 | Throat irritation | |
| 119101197 | 11910119 | Tongue discomfort | |
| 119101197 | 11910119 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119101197 | 11910119 | 1 | 20151120 | 0 | ||
| 119101197 | 11910119 | 2 | 20151120 | 0 |